Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $259 | $296 | $235 | $222 |
| Dep. & Amort. | $142 | $143 | $140 | $135 |
| Deferred Tax | $110 | $1 | $7 | $0 |
| Stock-Based Comp. | $20 | $21 | $22 | $27 |
| Change in WC | $35 | $55 | -$90 | $13 |
| Other Non-Cash | -$3 | $28 | $0 | $67 |
| Operating Cash Flow | $563 | $544 | $314 | $464 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$144 | -$108 | -$117 | -$123 |
| Net Acquisitions | -$34 | -$17 | $0 | -$383 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$23 | $1 | $2 | $4 |
| Investing Cash Flow | -$201 | -$124 | -$115 | -$502 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$216 | -$385 | -$1 |
| Stock Issued | $0 | $13 | $0 | $0 |
| Stock Repurch. | -$150 | $0 | $0 | -$151 |
| Dividends Paid | -$89 | -$90 | -$84 | -$84 |
| Other Fin. Act. | -$8 | $0 | -$92 | $66 |
| Financing Cash Flow | -$247 | -$293 | -$561 | -$170 |
| Forex Effect | -$2 | $4 | $1 | -$7 |
| Net Chg. in Cash | $113 | $131 | -$361 | -$215 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $319 | $188 | $549 | $764 |
| End Cash | $432 | $319 | $188 | $549 |
| Free Cash Flow | $419 | $436 | $197 | $341 |